Comment on 'The use of the EEG in measuring therapeutic drug action: focus on depression and antidepressants'.

about

Comment on 'The use of the EEG in measuring therapeutic drug action: focus on depression and antidepressants'.

Item

http://www.wikidata.org/entity/Q48642530

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh-hant

name

Comment on 'The use of the EEG ...... pression and antidepressants'.

@en

Comment on 'The use of the EEG ...... pression and antidepressants'.

@nl

type

Item

label

Comment on 'The use of the EEG ...... pression and antidepressants'.

@en

Comment on 'The use of the EEG ...... pression and antidepressants'.

@nl

prefLabel

Comment on 'The use of the EEG ...... pression and antidepressants'.

@en

Comment on 'The use of the EEG ...... pression and antidepressants'.

@nl

P1476

Comment on 'The use of the EEG ...... pression and antidepressants'.

@en

P2093

Aimee M Hunter

http://www.w3.org/2001/XMLSchema#string

Andrew Leuchter

http://www.w3.org/2001/XMLSchema#string

Ian A Cook

http://www.w3.org/2001/XMLSchema#string

P2860

Early changes in prefrontal activity characterize clinical responders to antidepressants

Subanesthetic dose of ketamine decreases prefrontal theta cordance in healthy volunteers: implications for antidepressant effect

Early reduction in prefrontal theta QEEG cordance value predicts response to venlafaxine treatment in patients with resistant depressive disorder

The change of prefrontal QEEG theta cordance as a predictor of response to bupropion treatment in patients who had failed to respond to previous antidepressant treatments

The antidepressant treatment response index and treatment outcomes in a placebo-controlled trial of fluoxetine.

The promise of the quantitative electroencephalogram as a predictor of antidepressant treatment outcomes in major depressive disorder.

The use of the EEG in measuring therapeutic drug action: focus on depression and antidepressants.

Comparative effectiveness of biomarkers and clinical indicators for predicting outcomes of SSRI treatment in Major Depressive Disorder: results of the BRITE-MD study.

Effectiveness of a quantitative electroencephalographic biomarker for predicting differential response or remission with escitalopram and bupropion in major depressive disorder.

Frontal EEG predictors of treatment outcome in major depressive disorder.

P304

1162-3; author reply 1164

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/0269881111430732

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22807041

http://www.w3.org/2001/XMLSchema#string